NO972024D0 - Metoder for diagnostisering av glaukom - Google Patents

Metoder for diagnostisering av glaukom

Info

Publication number
NO972024D0
NO972024D0 NO972024A NO972024A NO972024D0 NO 972024 D0 NO972024 D0 NO 972024D0 NO 972024 A NO972024 A NO 972024A NO 972024 A NO972024 A NO 972024A NO 972024 D0 NO972024 D0 NO 972024D0
Authority
NO
Norway
Prior art keywords
tigr
methods
glaucoma
diagnosing glaucoma
protein
Prior art date
Application number
NO972024A
Other languages
English (en)
Other versions
NO972024L (no
NO323252B1 (no
Inventor
Thai D Nguyen
Jon R Polansky
Weidong Huang
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO972024D0 publication Critical patent/NO972024D0/no
Publication of NO972024L publication Critical patent/NO972024L/no
Publication of NO323252B1 publication Critical patent/NO323252B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G01N2800/168—Glaucoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
NO19972024A 1994-11-03 1997-04-30 Hovedsakelig renset nukleinsyremolekyl, nukleinsyremolekyl, renset TIGR-protein, protein, anti-TIGR-antistoff eller antigen-bindingsfragment derav samt fremgangsmate for a diagnostisere glaukom NO323252B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/336,235 US5606043A (en) 1994-11-03 1994-11-03 Methods for the diagnosis of glaucoma
PCT/US1995/014024 WO1996014411A1 (en) 1994-11-03 1995-10-27 Methods for the diagnosis of glaucoma

Publications (3)

Publication Number Publication Date
NO972024D0 true NO972024D0 (no) 1997-04-30
NO972024L NO972024L (no) 1997-07-02
NO323252B1 NO323252B1 (no) 2007-02-12

Family

ID=23315160

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972024A NO323252B1 (no) 1994-11-03 1997-04-30 Hovedsakelig renset nukleinsyremolekyl, nukleinsyremolekyl, renset TIGR-protein, protein, anti-TIGR-antistoff eller antigen-bindingsfragment derav samt fremgangsmate for a diagnostisere glaukom

Country Status (12)

Country Link
US (3) US5606043A (no)
EP (1) EP0789762B1 (no)
JP (1) JP4099829B2 (no)
AT (1) ATE338818T1 (no)
AU (2) AU705420B2 (no)
CA (1) CA2204375C (no)
DE (1) DE69535214T2 (no)
MY (1) MY134914A (no)
NO (1) NO323252B1 (no)
NZ (1) NZ297601A (no)
WO (2) WO1996014411A1 (no)
ZA (1) ZA959256B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990099A (en) * 1988-10-31 1999-11-23 Alcon Laboratories, Inc. Angiostatic agents and methods and compositions for controlling ocular hypertension
US6271026B1 (en) 1997-03-21 2001-08-07 The University Of Iowa Research Foundation Glaucoma compositions
US6403307B1 (en) 1997-03-21 2002-06-11 University Of Iowa Research Foundation Glaucoma therapeutics and diagnostics
US5916778A (en) * 1994-04-28 1999-06-29 University Of Iowa Research Foundation Diagnostics based on a glaucoma causing gene
US5925748A (en) * 1994-04-28 1999-07-20 The University Of Iowa Research Foundation DNA diagnostics for glaucoma
US6956103B2 (en) 1994-04-28 2005-10-18 The University Of Iowa Research Foundation Glaucoma therapeutics and diagnostics
US6051573A (en) * 1994-06-28 2000-04-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists
US5849879A (en) * 1994-11-03 1998-12-15 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5606043A (en) 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5789169A (en) * 1994-11-03 1998-08-04 Regents Of The University Of California Methods for the diagnosis of glaucoma
US6117641A (en) 1996-04-11 2000-09-12 Mitotix, Inc. Assays and reagents for identifying anti-fungal agents and uses related thereto
JP2001513622A (ja) 1996-04-11 2001-09-04 マイトティックス インコーポレーテッド 抗菌剤の同定のためのアッセイおよび試薬、並びにそれらに関連する利用
US6727082B1 (en) 1996-04-11 2004-04-27 Gpc Biotech Inc. Assays and reagents for identifying anti-fungal agents, and uses related thereto
AU5436498A (en) * 1996-11-08 1998-05-29 University Of Iowa Research Foundation, The Glaucoma-associated protein and corresponding nucleic acid and their therapeut ic and diagnostic uses
ES2281918T3 (es) * 1996-12-05 2007-10-01 Alcon Manufacturing, Ltd. Metodos para diagnosticar glaucoma y descubrir farmacos antiglaucoma.
US7220546B2 (en) 1996-12-05 2007-05-22 Alcon Manufacturing, Ltd. Methods for diagnosing glaucoma and discovering anti-glaucoma drugs
US6171788B1 (en) * 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) * 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US5962230A (en) * 1997-02-13 1999-10-05 The University Of Connecticut Diagnosis and treatment of glaucoma
US5830661A (en) * 1997-02-13 1998-11-03 The University Of Connecticut Diagnosis and treatment of glaucoma
US20050123960A1 (en) * 1997-03-21 2005-06-09 Stone Edwin M. Glaucoma therapeutics and diagnostics
WO1998044108A1 (en) * 1997-04-01 1998-10-08 The Regents Of The University Of California Diagnosis and prognosis of glaucoma
WO1999016898A1 (en) * 1997-09-30 1999-04-08 Universite Laval Molecular diagnostic of glaucomas associated with chromosomes 1, and method of treatment thereof
US6090798A (en) * 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
US6066671A (en) * 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
US6646001B2 (en) 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
GB9812169D0 (en) 1998-06-05 1998-08-05 Univ Cambridge Tech Purification method
EP1126838A4 (en) 1998-10-30 2005-02-16 Nitromed Inc NITROSIS AND NITROSYAL NON-STEROID ANTI-INFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE
US6127128A (en) * 1999-05-07 2000-10-03 University Of Connecticut Diagnosis of primary congenital glaucoma
WO2000068429A2 (en) * 1999-05-07 2000-11-16 Institut National De La Sante Et De La Recherche Medicale (Inserm) Diagnosis of glaucoma
KR101072867B1 (ko) 2001-10-31 2011-10-17 유니버시티 오브 노스 텍사스 헬스 사이언스 센터 뼈 형태발생 단백질(ｂｍｐ), ｂｍｐ 수용체 및 ｂｍｐ 결합 단백질 및 녹내장 진단 및 치료에서 그의 용도
EP1777519A1 (en) * 2001-10-31 2007-04-25 Alcon, Inc. Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
US20030119000A1 (en) * 2001-11-05 2003-06-26 Jon Polansky Methods to screen and treat individuals with glaucoma or the propensity to develop glaucoma
US20030143601A1 (en) * 2001-11-16 2003-07-31 Hansen Thomas R. Methods and compositions for the detection of bovine pregnancy which utilize members of the 1-8 family of interferon inducible genes
GB0128816D0 (en) * 2001-12-01 2002-01-23 Univ Cambridge Tech Materials processing method and apparatus
US6727354B2 (en) * 2001-12-12 2004-04-27 Quest Diagnostics Investments, Inc. Compositions and methods for TIGR genotyping assays
TWI398261B (zh) * 2003-12-17 2013-06-11 Alcon Inc 血清類澱粉ａ基因於診斷及治療青光眼及鑑定抗青光眼劑上之用途
US20060105950A1 (en) * 2004-10-25 2006-05-18 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Morphogen compositions and use thereof to treat wounds
JP2009244125A (ja) 2008-03-31 2009-10-22 Nationa Hospital Organization 神経障害の検定のための組成物、キットおよび方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617299A (en) 1983-12-19 1986-10-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
US4757089A (en) 1985-06-14 1988-07-12 Massachusetts Eye And Ear Infirmary Increasing aqueous humor outflow
DE3612537C1 (de) 1986-04-14 1987-07-16 Dispersa Ag Arzneimittel zur Behandlung von Entzuendungen im Auge
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
JP2846018B2 (ja) 1988-01-21 1999-01-13 ジェネンテク，インコーポレイテッド 核酸配列の増幅および検出
IE63392B1 (en) 1988-02-08 1995-04-19 Insite Vision Inc Ophthalmic suspensions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
EP0425563B1 (en) 1988-07-20 1996-05-15 David Segev Process for amplifying and detecting nucleic acid sequences
US5124154A (en) 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5169766A (en) 1991-06-14 1992-12-08 Life Technologies, Inc. Amplification of nucleic acid molecules
US5516657A (en) * 1992-05-11 1996-05-14 Cambridge Biotech Corporation Baculovirus vectors for expression of secretory and membrane-bound proteins
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
US5606043A (en) * 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma

Also Published As

Publication number Publication date
ATE338818T1 (de) 2006-09-15
WO1998044107A1 (en) 1998-10-08
ZA959256B (en) 1996-08-14
AU4279296A (en) 1996-05-31
US5861497A (en) 1999-01-19
DE69535214T2 (de) 2007-08-02
US5606043A (en) 1997-02-25
US6248867B1 (en) 2001-06-19
DE69535214D1 (de) 2006-10-19
CA2204375C (en) 2006-04-11
NO972024L (no) 1997-07-02
EP0789762A1 (en) 1997-08-20
WO1996014411A1 (en) 1996-05-17
MY134914A (en) 2007-12-31
NO323252B1 (no) 2007-02-12
EP0789762B1 (en) 2006-09-06
JPH10509866A (ja) 1998-09-29
MX9703194A (es) 1997-07-31
AU2432897A (en) 1998-10-22
NZ297601A (en) 1999-04-29
JP4099829B2 (ja) 2008-06-11
AU705420B2 (en) 1999-05-20
CA2204375A1 (en) 1996-05-17

Similar Documents

Publication Publication Date Title
NO972024L (no) Metoder for diagnostisering av glaukom
DE68927459D1 (de) Nachweis einer neurologischen Krankheit oder einer Funktionsstörung
YU48442B (sh) Postupak za dobivanje monoklonalnog antitela okt 3
DE69529076D1 (de) Verfahren und testsätze zur spezifischen und empfindlichen diagnose periodontaler erkrankungen
FI964845A0 (fi) CD44v6:n vastaiset monoklonaaliset vasta-aineet
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
ATE245699T1 (de) Rekombinant pgp3, verfahren zu dessen herstellung,und dessen verwendung in der diagnose und therapie
ES2104770T3 (es) Metodo para diagnosticar enfermedades renales por deteccion de fragmentos de albumina.
ATE159300T1 (de) Monoklonale antikörper gegen menschliches ige
BR9509317A (pt) Antagonista a interleucina-1
GB9014220D0 (en) Method for the immunlolgical determinition of the carboxyterminal propeptide of type i procollagen
ES2052913T3 (es) Ensayo inmunoquimico en cuanto al factor estimulante de colonias de granulocitos-macrofagos.
IT1239719B (it) Uso dell'anticorpo monoclonale sp-2 nella diagnostica clinica ed il monitoraggio del progredire dell'infezione hiv
JPS55135752A (en) Determination method of immunogloblin e in human blood by enzyme immunity measuring method
SU1119656A1 (ru) Способ диагностики саркоидоза
JPS6486067A (en) Diagnosis and kit for bloom syndrome
RU95111046A (ru) Способ диагностики синдрома поликистозных яичников
KR970073606A (ko) 항 인체 인터루킨-6 항체 및 이를 이용한 인체 인터루킨-6의 검정
RU95101284A (ru) Способ диагностики инфаркта кишечника
ITMI921385A1 (it) Anticorpi monoclonali e corredi diagnostici che li contengono per la diagnosi ed il monitoraggio di malattie infiammatorie ed
ITMI931172A0 (it) Anticorpi monoclonati e corredi diagnostici che li contengono per la diagnosi ed il monitoraggio di malattie infiammatorie ed autoimmunitarie
RU98121265A (ru) Способ диагностики субклинических и начальных форм демиелинизирующих полиневропатий

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees